Skip to main content

Matthew Hirschey

Associate Professor of Medicine
Medicine, Endocrinology, Metabolism, and Nutrition
104775, Room 50-201, Durham, NC 27701
300 N. Duke Street, 50-201, Durham, NC 27701

Overview


The Hirschey Lab in the Duke Molecular Physiology Institute, and the Departments of Medicine and Pharmacology & Cancer Biology at Duke University studies different aspects of metabolic control, mitochondrial signaling, and cellular processes regulating human health and disease.

Current Appointments & Affiliations


Associate Professor of Medicine · 2019 - Present Medicine, Endocrinology, Metabolism, and Nutrition, Medicine
Associate Professor in Pharmacology and Cancer Biology · 2019 - Present Pharmacology & Cancer Biology, Basic Science Departments
Associate Professor of Cell Biology · 2022 - Present Cell Biology, Basic Science Departments
Member of Sarah W. Stedman Nutrition and Metabolism Center · 2011 - Present Sarah Stedman Nutrition & Metabolism Center, Duke Molecular Physiology Institute
Member of the Duke Cancer Institute · 2012 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published February 8, 2024
The AI Explosion, Explained
Published July 10, 2023
New University Course Offers a Technical and Ethical Exploration of Our Data-Centric World
Published May 12, 2023
Navigating AI at Duke

View All News

Recent Publications


Caenorhabditis elegans fed native gut microbiota have altered bioenergetic pathway utilization impacting mitochondrial function and susceptibility to pollutants.

Journal Article Environ Sci Process Impacts · April 2, 2026 The gut microbiome can influence host health by facilitating digestion, immune function, and xenobiotic metabolism. Microbial metabolites can influence mitochondrial function by shifting bioenergetic pathways, potentially altering sensitivity to mitochondr ... Full text Link to item Cite

In vivo imaging of metabolic heterogeneity across three endpoints relevant to aggressive breast cancer.

Journal Article PNAS Nexus · March 2026 Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with poor prognosis and a high likelihood of recurrence. Residual disease after therapy is a key predictor of recurrence, often driven by intratumoral metabolic heterogeneity. A ... Full text Link to item Cite

datadrivenhypothesis.org: A resource for metabolic gene discovery through integrated pathway co-essentiality mapping.

Journal Article bioRxiv · February 12, 2026 datadrivenhypothesis.org (DDH) integrates gene dependency, expression, literature data, and beyond from ~20,000 human genes to reveal hidden metabolic connections. Through pathway-level co-essentiality analysis with novelty scoring, DDH uncovered unexpecte ... Full text Link to item Cite
View All Publications

Recent Grants


Pharmacological Sciences Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030

Unified Program for Therapeutics in Children

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030

Stimulating Access to Research in Residency (StARR) - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of Allergy and Infectious Diseases · 2018 - 2029

View All Grants

Education


University of California, Santa Barbara · 2006 Ph.D.